1. Home
  2. TTC vs NUVL Comparison

TTC vs NUVL Comparison

Compare TTC & NUVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Toro Company (The)

TTC

Toro Company (The)

HOLD

Current Price

$99.46

Market Cap

8.8B

ML Signal

HOLD

Logo Nuvalent Inc.

NUVL

Nuvalent Inc.

HOLD

Current Price

$99.24

Market Cap

8.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TTC
NUVL
Founded
1914
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Tools/Hardware
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.8B
8.1B
IPO Year
1994
2021

Fundamental Metrics

Financial Performance
Metric
TTC
NUVL
Price
$99.46
$99.24
Analyst Decision
Buy
Strong Buy
Analyst Count
4
15
Target Price
$91.00
$135.33
AVG Volume (30 Days)
791.7K
443.1K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
1.58%
N/A
EPS Growth
N/A
N/A
EPS
0.69
N/A
Revenue
$2,618,650,000.00
N/A
Revenue This Year
$4.34
N/A
Revenue Next Year
$4.57
$1,064.25
P/E Ratio
$31.16
N/A
Revenue Growth
4.53
N/A
52 Week Low
$62.34
$55.54
52 Week High
$105.19
$113.02

Technical Indicators

Market Signals
Indicator
TTC
NUVL
Relative Strength Index (RSI) 58.40 42.84
Support Level $96.54 $98.65
Resistance Level $102.32 $107.13
Average True Range (ATR) 2.61 4.05
MACD -0.64 -0.31
Stochastic Oscillator 33.78 19.28

Price Performance

Historical Comparison
TTC
NUVL

About TTC Toro Company (The)

The Toro Co designs, manufactures, markets, and sells professional turf maintenance equipment and services; turf and agricultural irrigation systems; landscaping equipment and lighting products; snow and ice management equipment; construction equipment; and residential yard and snow thrower products. The company operates through Professional and Residential segments, with the Professional segment serving commercial, agricultural, and construction customers and generating the majority of revenue, while the Residential segment focuses on homeowners. Its products are sold through distributors, dealers, retailers, rental centers, and direct channels, with the United States as its primary revenue-generating market.

About NUVL Nuvalent Inc.

Nuvalent Inc is a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer. All of its operations are in the United States. The company is engaged in developing small molecules that are designed to overcome the limitations of existing therapies for clinically validated kinase targets. The product candidates of the company include NVL-520, which is being developed for patients with ROS1-positive non-small cell lung cancer (NSCLC), NVL-655, which is being developed for patients with anaplastic lymphoma kinase (ALK)-positive NSCLC, NVL-330, is a brain-penetrant human epidermal growth factor receptor 2 (HER2)-selective inhibitor designed to address the combined medical need of treating tumors driven by HER2ex20.

Share on Social Networks: